Lennikov, Anton <br/><br/>
Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis.  [electronic resource] 

 -  Angiogenesis  05 2018 
 - 267-285 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7209 
<br/><br/><label>Standard No.: </label>10.1007/s10456-018-9594-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Benzamides--pharmacology<br/>Cornea--metabolism<br/>Corneal Neovascularization--drug therapy<br/>Eye Proteins--antagonists & inhibitors<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>I-kappa B Kinase--antagonists & inhibitors<br/>Keratitis--drug therapy<br/>Male<br/>NF-kappa B--genetics<br/>Rats<br/>Rats, Wistar<br/>Signal Transduction--drug effects<br/>Zebrafish